R Scott Turner, PhD, MD

home / authors / r-scott-turner-phd-md

Articles

Patient Selection for Lecanemab to treat Early Alzheimer Dementia with R Scott Turner, PhD, MD

Patient Selection for Lecanemab to Treat Early Alzheimer Dementia: Details with R Scott Turner, PhD, MD

R Scott Turner, PhD, MD;Grace Halsey

January 28th 2025

Dr Turner reviews the profile of the individual who is most likely to benefit from lecanemab therapy.

Lecanemab Monthly IV Maintenance Dosing: Research Highlights with R Scott Turner, PhD, MD

R Scott Turner, PhD, MD;Grace Halsey

January 27th 2025

Georgetown University memory disorders expert R Scott Turner, PhD, MD, reviews the science behind approval of lecanemab for monthly maintenance dosing of lecanemab.

Anti-Amyloid Antibodies in Short: R Scott Turner, PhD, MD Explains

R Scott Turner, PhD, MD;Grace Halsey

January 24th 2025

The revolutionary medications are the first new treatments for Alzheimer disease to be approved in more than 20 years and the first-ever disease-modifying drugs.